<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Head and Neck Tumors</journal-id><journal-title-group><journal-title xml:lang="en">Head and Neck Tumors</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли головы и шеи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-1468</issn><issn publication-format="electronic">2411-4634</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1088</article-id><article-id pub-id-type="doi">10.17650/2222-1468-2026-16-1-55-63</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ ГОЛОВЫ И ШЕИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Traditional transoral approach and lateral pharyngotomy in surgical treatment of T1–2 oropharyngeal cancer</article-title><trans-title-group xml:lang="ru"><trans-title>Традиционный чрезротовой доступ и боковая фаринготомия в хирургическом лечении рака ротоглотки категории Т1–2</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4756-1310</contrib-id><name-alternatives><name xml:lang="en"><surname>Karpenko</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Карпенко</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andrei_karpenko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3219-4420</contrib-id><name-alternatives><name xml:lang="en"><surname>Sibgatullin</surname><given-names>R. R.</given-names></name><name xml:lang="ru"><surname>Сибгатуллин</surname><given-names>Р. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andrei_karpenko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1400-7775</contrib-id><name-alternatives><name xml:lang="en"><surname>Boyko</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Бойко</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andrei_karpenko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3658-4493</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikolaeva</surname><given-names>O. M.</given-names></name><name xml:lang="ru"><surname>Николаева</surname><given-names>О. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andrei_karpenko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5861-190X</contrib-id><name-alternatives><name xml:lang="en"><surname>Kucherenko</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Кучеренко</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andrei_karpenko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7818-5429</contrib-id><name-alternatives><name xml:lang="en"><surname>Alekseev</surname><given-names>S. M.</given-names></name><name xml:lang="ru"><surname>Алексеев</surname><given-names>С. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andrei_karpenko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Leningrad Regional Clinical Hospital</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Ленинградская областная клиническая больница»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-06-09" publication-format="electronic"><day>09</day><month>06</month><year>2026</year></pub-date><volume>16</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>55</fpage><lpage>63</lpage><history><date date-type="received" iso-8601-date="2025-09-29"><day>29</day><month>09</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, АБВ-пресс</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://ogsh.abvpress.ru/jour/article/view/1088">https://ogsh.abvpress.ru/jour/article/view/1088</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> Growing incidence of oropharyngeal cancer is one of the reasons for increased interest in possibilities of surgical treatment of this pathology which currently is associated with not always available robot-assisted interventions. Therefore, study of the efficacy of traditional surgical accesses is of certain interest.</p> <p><bold>Aim.</bold> To analyze the effectiveness of transoral access and lateral pharyngotomy in T1–2 squamous cell oropharyngeal cancer.</p> <p><bold>Materials and methods.</bold> The study included 74 patients, ages between 34 and 74 years (mean age 55.3 ± 9.1), with squamous cell carcinoma of the palatine tonsils and root of the tongue. In 38 cases, primary tumor was resected through transoral access (group 1); in 36 cases, using lateral pharyngotomy (group 2). Analysis of postoperative period included evaluation of the number and type of complications, number of repeat surgical interventions, duration of tube feeding and hospitalization. Treatment efficacy was determined taking into account the incidence of local and regional recurrences, locoregional control, and overall survival.</p> <p><bold>Results.</bold> Complication rate, mean tube feeding and hospitalization times in the 2nd group were significantly higher than in the 1st group: 36 % versus 3 %, 14.3 days <italic>versus</italic> 10.6 days and 17.0 days versus 10.4 days, respectively. No differences between the numbers of repeat surgeries and cases of salivary fistula formation were found. With median follow-up of 47 (4–122) months, rates of local and regional recurrences in the 1st and 2nd groups were 11 and 11 %, 11 and 13 %, respectively. In group 1, locoregional control was achieved in 84 % patients; in group 2, in 81 %. Distant metastases were diagnosed in 8 and 17 % cases, respectively. There were no statistically significant differences in this parameter between the groups. Five-year overall survival in the total cohort was 71.2 %.</p> <p><bold>Conclusion.</bold> The use of transoral access and lateral pharyngotomy in T1–2 oropharyngeal cancer is characterized by relatively high efficacy and acceptable rate of postoperative complications.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> Рост заболеваемости раком ротоглотки стал одной из причин возрастания интереса к возможностям хирургического метода лечения данной патологии, который в настоящее время ассоциируется с не всегда доступными роботизированными вмешательствами. В связи с этим изучение эффективности традиционных хирургических доступов может представлять определенный интерес.</p> <p><bold>Цель исследования</bold> – анализ эффективности применения чрезротового доступа и боковой фаринготомии при плоскоклеточном раке ротоглотки Т1–2.</p> <p><bold>Материалы и методы.</bold> В исследование включены 74 пациента в возрасте от 34 до 74 лет (средний возраст – 55,3 ± 9,1 года) с плоскоклеточным раком небной миндалины и корня языка. В 38 случаях первичная опухоль удалена с помощью чрезротового доступа (группа 1), в 36 случаях – с использованием боковой фаринготомии (группа 2). Для анализа течения послеоперационного периода оценивали количество и характер осложнений, число повторных хирургических вмешательств, а также продолжительность зондового питания и госпитализации. Эффективность лечения определяли с учетом частоты развития местного и регионарного рецидивов, локорегионарного контроля над заболеванием и общей выживаемости.</p> <p><bold>Результаты.</bold> Частота развития осложнений, средняя продолжительность зондового питания и госпитализации в группе 2 были значимо выше, чем в группе 1: 36 % против 3 %, 14,3 дня против 10,6 дня и 17 дней против 10,4 дня соответственно. Различий в количестве повторных операций и числе случаев формирования слюнного свища выявлено не было. При медиане наблюдения 47 (4–122) мес частота развития местного и регионарного рецидивов в группах 1 и 2 составила 11 и 11 %, 11 и 13 % соответственно. В группе 1 локорегионарный контроль достигнут у 84 % пациентов, в группе 2 – у 81 %. Отдаленные метастазы диагностированы в 8 и 17 % случаев соответственно. Статистически значимых различий по этому показателю выявлено не было. Общая 5-летняя выживаемость во всей когорте больных составила 71,2 %.</p> <p><bold>Заключение.</bold> Применение традиционного чрезротового доступа и боковой фаринготомии при раке ротоглотки Т1–2 характеризуется довольно высокой эффективностью и приемлемой частотой послеоперационных осложнений.</p></trans-abstract><kwd-group xml:lang="en"><kwd>oropharyngeal carcinoma</kwd><kwd>transoral approach</kwd><kwd>lateral pharyngotomy</kwd><kwd>surgical approach</kwd><kwd>postoperative complication</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак ротоглотки</kwd><kwd>чрезротовой доступ</kwd><kwd>боковая фаринготомия</kwd><kwd>хирургический доступ</kwd><kwd>послеоперационное осложнение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Wilkie M.D., Upile N.S., Lau A.S. et al. Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: a paradigm shift in therapeutic approach. Head Neck 2016;38(8):1263–70. DOI: 10.1002/hed.24432</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Justesen M.M., Jakobsen K.K., Carlander A-L.F. et al. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: a consecutive single-institution study from 2013 to 2020. Oral Oncol 2024;152:106783. DOI: 10.1016/j.oraloncology.2024.106783</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Zumsteg Z.S., Luu M., Rosenberg P.S. et al. Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst 2023;115(12):1544–54. DOI: 10.1093/jnci/djad169</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gupta K.K., De M., Athanasiou T. et al. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol 2024;50(7):108434. DOI: 10.1016/j.ejso.2024.108434</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jacobs D., Torabi S.J., Park H.S. et al. Revisiting the radiation therapy oncology group 1221 hypothesis: treatment for stage III/IV HPV-negative oropharyngeal cancer. Otolaryngol Head Neck Surg 2021;164(6):1240–8. DOI: 10.1177/0194599820969613</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Rahmati R., Dogan S., Pyke O. et al. Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation. Head Neck 2015;37(6):800–7. DOI: 10.1002/hed.23679</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Tirelli G., Bertolin A., Guida F. et al. Postoperative outcomes of different surgical approaches to oropharyngeal squamous cell cancer: a case-matched study. J Laryngol Otol 2021;135(4):348–54. DOI: 10.1017/S0022215121000876</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Laccourreye O., Villeneuve A., Rubin F., Holsinger F.C. Lateral pharyngotomy. Eur Ann Otorhinolaryngol Head Neck Dis 2019;136(2):135–40. DOI: 10.1016/j.anorl.2018.10.011</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Lee S.Y., Park Y.M., Byeon H.K. et al. Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer. Head Neck 2014;36(8):1138–45. DOI: 10.1002/hed.23424</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Golusiński W., Golusińska-Kardach E. Current role of surgery in the management of oropharyngeal cancer. Front Oncol 2019;9:388. DOI: 10.3389/fonc.2019.00388</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Holsinger F.C., McWhorter A.J., Ménard M. et al. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg 2005;131(7):583–91. DOI: 10.1001/archotol.131.7.583</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Bertolin A., Ghirardo G., Lionello M. et al. Lateral pharyngotomy approach in the treatment of oropharyngeal carcinoma. Eur Arch Otorhinolaryngol 2017;274(6):2573–80. DOI: 10.1007/s00405-017-4538-3</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Laccourreye O., Malinvaud D., Alzahrani H. et al. Conventional transoral surgery for stage I–II squamous cell carcinoma of the tonsillar region. Head Neck 2013;35(5):653–9. DOI: 10.1002/hed.23018</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rodrigo J.P., Díaz-Molina J.P., Moreno C., Suárez C. Oncologic and functional results after transhyoid surgical approach for cancer for the base of tongue. Head Neck 2011;33(8):1079–84. DOI: 10.1002/hed.21569</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Meccariello G., Bianchi G., Calpona S. et al. Transoral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience. Oral Oncol 2020;110:104889. DOI: 10.1016/j.oraloncology.2020.104889</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Trotter W. A method for lateral pharyngotomy for the exposure of large growths in the epilaryngeal region. J Laryngol Rhinol Otol 1920;35(10):289–95. DOI: 10.1017/S1755146300021181</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Moore E.J., Van Abel K.M., Price D.L. et al. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes. Head Neck 2018;40(4):747–75. DOI: 10.1002/hed.25055</mixed-citation></ref></ref-list></back></article>
